A protein-centric approach for exome variant aggregation enables sensitive association analysis with clinical outcomes

Ginny X.H. Li, Dan Munro, Damian Fermin, Christine Vogel, Hyungwon Choi

Research output: Contribution to journalArticle

Abstract

Somatic mutations are early drivers of tumorigenesis and tumor progression. However, the mutations typically occur at variable positions across different individuals, resulting in the data being too sparse to test meaningful associations between variants and phenotypes. To overcome this challenge, we devised a novel approach called Gene-to-Protein-to-Disease (GPD) which accumulates variants into new sequence units as the degree of genetic assault on structural or functional units of each protein. The variant frequencies in the sequence units were highly reproducible between two large cancer cohorts. Survival analysis identified 232 sequence units in which somatic mutations had deleterious effects on overall survival, including consensus driver mutations obtained from multiple calling algorithms. By contrast, around 76% of the survival predictive units had been undetected by conventional gene-level analysis. We demonstrate the ability of these signatures to separate patient groups according to overall survival, therefore, providing novel prognostic tools for various cancers. GPD also identified sequence units with somatic mutations whose impact on survival was modified by the occupancy of germline variants in the surrounding regions. The findings indicate that a patient's genetic predisposition interacts with the effect of somatic mutations on survival outcomes in some cancers.

Original languageEnglish (US)
Pages (from-to)934-945
Number of pages12
JournalHuman Mutation
Volume41
Issue number5
DOIs
StatePublished - May 1 2020

Keywords

  • exome sequence variants
  • prognostic signatures
  • sequence units

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'A protein-centric approach for exome variant aggregation enables sensitive association analysis with clinical outcomes'. Together they form a unique fingerprint.

  • Cite this